IP Library Granted Patent US 8,716,477
Granted Patent B2
US 8,716,477 · App. 13/509,125 · Granted May 6, 2014

Crystalline forms of bosentan salts and processes for their preparation

Inventors: Rakesh Singh (Jaunpur, IN); Anu Mittal (Kurukshetra, IN); Gopal Singh Bisht (New Delhi, IN); Mahavir Singh Khanna (New Delhi, IN); Rajesh Kumar Thaper (Jammu, IN); Mohan Prasad (Gurgaon, IN)
Assignee: Ranbaxy Laboratories Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,716,477
App. No.
13/509,125
Granted
May 6, 2014
Kind
B2
Abstract

The present invention relates to crystalline forms of bosentan salts and processes for their preparation.(FORMULA)

Claims (11)

1. Crystalline Form A of bosentan potassium having an XRPD pattern comprising interplanar spacing (d) values substantially at 3.31, 3.70, 3.73, 3.82, 4.00, 4.26, 4.44, 4.55, 4.74, 4.84, 4.96, 5.29, 5.49, 8.74, 13.78, 14.76, 15.97, 19.89, and 21.54 (Å).

2. Crystalline Form A of bosentan potassium having an XRPD pattern substantially as depicted in FIG. 1 or the DSC pattern substantially as depicted in FIG. 3 .

3. A process for preparing crystalline Form A of bosentan potassium, wherein the process comprises:

a) treating bosentan with a potassium ion source in the presence of an organic solvent or a mixture of organic solvents; and

b) isolating crystalline Form A of bosentan potassium from the mixture thereof.

4. A process for preparing crystalline Form A of bosentan potassium, wherein the process comprises:

a) treating bosentan potassium with a first organic solvent;

b) treating the mixture obtained in step a) with a second organic solvent; and

c) isolating crystalline Form A of bosentan potassium from the mixture thereof.

5. Crystalline Form A of bosentan potassium prepared according to claim 3 or 4 , having a purity of about 98% or above.

6. Crystalline Form A of bosentan potassium prepared according to claim 3 or 4 , having a purity of about 99% or above.

Assignments (2)
MERGER Recorded Jan 13, 2016
From: RANBAXY LABORATORIES LIMTED
To: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Reel/Frame 037513/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2012
From: SINGH, RAKESH; MITTAL, ANU; BISHT, GOPAL SINGH; KHANNA, MAHAVIR SINGH; THAPER, RAJESH KUMAR; PRASAD, MOHAN
To: RANBAXY LABORATORIES LIMITED
Reel/Frame 028218/0927 →
Priority Claims (1)
IN 2339/DEL/2009 · Nov 12, 2009 · national
Continuity (1)
Related Publication 20120283440A1 · Nov 8, 2012